Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study

Early stereotactic body radiation therapy (SBRT) to the primary tumor combined with epidermal growth factor receptor tyrosine kinase inhibitor (EFGR-TKI) treatment may increase progression-free survival (PFS) by delaying resistance in patients with advanced EGFR-mutant non-small cell lung cancer (NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yangyang, Xu, Hailing, Raynor, William Y., Ding, Jiapei, Lin, Ling, Zhou, Chao, Wang, Wei, Meng, Yinnan, Wu, Xiaomai, Chen, Xiaofeng, Lv, Dongqing, Yang, Haihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783042/
https://www.ncbi.nlm.nih.gov/pubmed/36556319
http://dx.doi.org/10.3390/life12121954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783042/
https://www.ncbi.nlm.nih.gov/pubmed/36556319
http://dx.doi.org/10.3390/life12121954

Ejemplares similares